ENDRA Life Sciences Inc (NASDAQ: NDRA) is -94.79% lower on its value in year-to-date trading and has touched a low of $2.90 and a high of $170.62 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NDRA stock was last observed hovering at around $3.46 in the last trading session, with the day’s gains setting it 4.84%.
Currently trading at $8.3, the stock is 125.29% and 110.41% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 90.6 million and changing 140.12% at the moment leaves the stock 58.99% off its SMA200. NDRA registered 32.59% gain for a year compared to 6-month loss of 28.88%. The firm has a 50-day simple moving average (SMA 50) of $3.94472 and a 200-day simple moving average (SMA200) of $5.220545.
The stock witnessed a 145.56% gain in the last 1 month and extending the period to 3 months gives it a 134.46%, and is 136.47% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 20.61% over the week and 9.52% over the month.
ENDRA Life Sciences Inc (NDRA) has around 21 employees, a market worth around $6.12M and $0.00M in sales. Distance from 52-week low is 186.21% and -95.14% from its 52-week high. The company has generated returns on investments over the last 12 months (-441.20%).
The EPS is expected to grow by 83.14% this year.
ENDRA Life Sciences Inc (NDRA) Top Institutional Holders
2.0 institutions hold shares in ENDRA Life Sciences Inc (NDRA), with institutional investors hold 0.15% of the company’s shares. The shares outstanding are 0.74M, and float is at 0.74M with Short Float at 2.29%. Institutions hold 0.15% of the Float.
ENDRA Life Sciences Inc (NDRA) Insider Activity
The most recent transaction is an insider purchase by UBS Group AG,the company’s10% Owner. SEC filings show that UBS Group AG bought 3,715 shares of the company’s common stock on Aug 27 ’24 at a price of $0.55 per share for a total of $2052.0. Following the purchase, the insider now owns 0.15 million shares.
